- Home
- ELTK vs IKNA Comparison
ELTK vs IKNA Comparison
Compare ELTK & IKNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELTK
- IKNA
- Stock Information
- Founded
- ELTK 1970
- IKNA 2016
- Country
- ELTK Israel
- IKNA United States
- Employees
- ELTK N/A
- IKNA N/A
- Industry
- ELTK Electrical Products
- IKNA Biotechnology: Pharmaceutical Preparations
- Sector
- ELTK Technology
- IKNA Health Care
- Exchange
- ELTK Nasdaq
- IKNA Nasdaq
- Market Cap
- ELTK 73.9M
- IKNA 80.8M
- IPO Year
- ELTK 1997
- IKNA 2021
- Fundamental
- Price
- ELTK $11.17
- IKNA $1.71
- Analyst Decision
- ELTK
- IKNA Buy
- Analyst Count
- ELTK 0
- IKNA 2
- Target Price
- ELTK N/A
- IKNA $3.00
- AVG Volume (30 Days)
- ELTK 21.9K
- IKNA 59.9K
- Earning Date
- ELTK 11-19-2024
- IKNA 11-07-2024
- Dividend Yield
- ELTK 1.99%
- IKNA N/A
- EPS Growth
- ELTK N/A
- IKNA N/A
- EPS
- ELTK 0.85
- IKNA N/A
- Revenue
- ELTK $48,090,000.00
- IKNA $659,000.00
- Revenue This Year
- ELTK $5.41
- IKNA N/A
- Revenue Next Year
- ELTK $12.11
- IKNA N/A
- P/E Ratio
- ELTK $13.00
- IKNA N/A
- Revenue Growth
- ELTK 7.22
- IKNA N/A
- 52 Week Low
- ELTK $9.00
- IKNA $1.22
- 52 Week High
- ELTK $22.80
- IKNA $2.32
- Technical
- Relative Strength Index (RSI)
- ELTK 54.37
- IKNA 49.85
- Support Level
- ELTK $10.82
- IKNA $1.71
- Resistance Level
- ELTK $12.00
- IKNA $1.77
- Average True Range (ATR)
- ELTK 0.41
- IKNA 0.05
- MACD
- ELTK 0.03
- IKNA -0.00
- Stochastic Oscillator
- ELTK 42.36
- IKNA 38.46
About ELTK Eltek Ltd.
Eltek Ltd is engaged in the technology business sector that manufactures and supplies technologically new custom-made circuitry solutions. It manufactures, markets, and sells custom-made printed circuit boards (PCBs), including high-density interconnects. The Company markets its products mainly to the medical technology, defense and aerospace, industrial, telecom, and networking equipment industries. Its geographic areas are Israel, North America, the Netherlands, India, and Others. It generates the majority of its revenue from Israel.
About IKNA Ikena Oncology Inc.
Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.